Blends & stacks
The superhero names are just stories.
Wolverine, Deadpool, Glow, KLOW. These named blends are packaging and marketing, not pharmacology. The individual peptides inside each one have their own (mostly thin) evidence. The blends themselves, as blends, have none: not one human or animal study has ever tested any of them combined. Every blend below grades E for the combination. We know because we looked.
Why one vial is self-defeating
Even when each component is individually reasonable, locking them together into one vial breaks the pharmacology. This isn't our opinion. It's just how peptides work.
Different dose magnitudes
A blend can hold GHK-Cu at 50 mg next to BPC-157 in micrograms, a 5–10× gap frozen in one vial. A single syringe draw can't deliver a correct dose of both at once.
Different half-lives, different cadences
BPC-157's half-life is minutes, so it's dosed daily; TB-500 acts over days, so it's dosed about twice a week. One vial forces a single schedule onto molecules whose ideal frequencies differ roughly sevenfold.
You can't titrate it
Respond well to one component, or react badly to another, and you can't adjust it without dragging the rest along. That destroys any ability to know what's working, or what caused a side effect.
Borrowed identity
What's sold as 'TB-500' isn't even the molecule its evidence comes from, it's a short fragment. So a blend's healing claims often borrow from a different compound than what's actually in the vial.
Do the math
Take KLOW, four peptides, 80 mg total. Reconstitute it the way vendors instruct (about 3 mL of water) and one insulin unit delivers roughly 267 mcg of total blend: about 167 mcg of GHK-Cu plus ~33 mcg each of KPV, BPC-157, and TB-500. That ratio is locked at manufacture. You cannot raise the BPC-157 without also raising the GHK-Cu and dragging KPV and TB-500 along. Four molecules, four ideal doses, four ideal schedules, one syringe.
What we found in each blend
Wolverine
Injury & recovery
The pitch: Two supposedly non-overlapping healing pathways. BPC-157 working locally at the injury, TB-500 working systemically.
No study has ever tested the pair together. The synergy is reverse-engineered from each compound's separate, and individually weak, literature.
Deadpool
Joint & recovery
The pitch: Wolverine plus a cartilage / anti-inflammatory peptide, pitched for 'structured tissue recovery.'
Three peptides, zero combination studies, and three different ideal doses fighting over one syringe. The extra peptide multiplies the problem, not the proof.
On Nexaph the third ingredient is Cartalax (a cartilage bioregulator); other vendors' Deadpool uses KPV. “Cardilax” is a misnomer, see below.
Glow
Skin & anti-aging
The pitch: GHK-Cu drives collagen while BPC-157 and TB-500 add repair, marketed as the aesthetic upgrade to Wolverine.
Defensible mechanisms, but no human study of the blend, and the ~5× dose gap between the GHK-Cu and the others is locked into the vial.
KLOW
Skin & healing
The pitch: Glow plus KPV for extra anti-inflammatory action, the 'everything' blend.
Four peptides, four ideal schedules, one syringe. The clearest illustration anywhere of why fixed multi-peptide vials are indefensible, see the math above.
Beauty
Skin
The pitch: Copper peptide for collagen plus KPV to calm inflammation.
A two-peptide skin blend with no combination data, and GHK-Cu's own evidence is mostly topical, not injected.
Tesamorelin + Ipamorelin
Growth hormone
The pitch: A GHRH analog plus a ghrelin-mimetic, together they amplify the body's own growth-hormone pulse.
The exception that proves the rule. The GHRH + GHRP synergy is genuinely human-documented (the mechanism grades B). But the specific ratio and the anti-aging benefit are still convention. D for the blend. This is the benchmark the others fail to meet.
The CJC-1295 + Ipamorelin blend works the same way (a GHRH analog + a GHRP).
A word on “Cardilax”
If you see “Cardilax” on a peptide label, stop. There is no peptide called Cardilax. The name almost certainly means Cartalax, a real cartilage bioregulator peptide, and the actual third ingredient in some Deadpool blends. But the spelling “Cardilax” is an unrelated anxiety tablet (alprazolam + propranolol), and “cardi-” confusion has sent people toward Cardarine (GW-501516), which is not a peptide at all. It's a research chemical that caused multi-organ cancer in animal studies and was abandoned by its maker. When you can't reliably name what's in the vial, there is no science underneath it.
These are the blends we've graded so far; we're adding single compounds to the catalog as we go. See what we've covered on the graded index.